Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (181-190 of 458) with videos related to

Pageof 46
Sort By:
American Journal of Medical Genetics. Part A|January 22, 2020
Tatton-Brown-Rahman syndrome: Six individuals with novel featuresTugce B Balci, Alana Strong, Jennifer M Kalish, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Genomics|July 1, 1996
Physical mapping and genomic structure of the human TNFR2 geneC P Beltinger, P S White, J M Maris, et al.
The Lancet. Child & Adolescent Health|January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trialPedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Pediatric Blood & Cancer|June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing programMimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|August 19, 2014
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing programPeter J Houghton, Raushan T Kurmasheva, Dmitry Lyalin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I studyKatherine K Matthay, Alekist Quach, John Huberty, et al.
Pageof 46

Showing results (181-190 of 458) with videos related to

Sort By:
Pageof 46
American Journal of Medical Genetics. Part A|January 22, 2020
Tatton-Brown-Rahman syndrome: Six individuals with novel featuresTugce B Balci, Alana Strong, Jennifer M Kalish, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Genomics|July 1, 1996
Physical mapping and genomic structure of the human TNFR2 geneC P Beltinger, P S White, J M Maris, et al.
The Lancet. Child & Adolescent Health|January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trialPedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Pediatric Blood & Cancer|June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing programMimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|August 19, 2014
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing programPeter J Houghton, Raushan T Kurmasheva, Dmitry Lyalin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I studyKatherine K Matthay, Alekist Quach, John Huberty, et al.
Pageof 46